Vimarsana
Biggest News Aggregation in the World

Accenture Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accenture Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accenture Life Sciences Today - Breaking & Trending Today

Accenture Invests in QuantHealth to Accelerate Use of AI-powered Clinical Trial Simulations to Drive Cost-Effective Drug Development - Vimarsana News

Accenture Invests in QuantHealth to Accelerate Use of AI-powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Accenture announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing...

AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development - Vimarsana News

AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development

AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development

AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development - Vimarsana News

AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development

Leading biopharmaceutical company taps AWS and Accenture for technology modernization ...

Biologics and beer: What goes on at the ALE Lab? - Vimarsana News

Biologics and beer: What goes on at the ALE Lab?

Accenture's Dara Bell talks to us about the work being done at the ALE Lab and what Accenture looks for in candidates.

Protecting Cell And Gene Therapy RD Against Cyber Threats - Vimarsana News

Protecting Cell And Gene Therapy RD Against Cyber Threats

Depending on the size of the organization, the transparency of its CGT R&D laboratories, and the timeframe for accelerated approval, the concept...